One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-148473
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 14 |
Affiliation: The University of Texas MD Anderson Cancer Center, Marshfield Clinic, Fred Hutch Cancer Center, Columbia University Irving Medical Center, Fox Chase Cancer Center, Hôpital Lyon Sud, Ronald Reagan UCLA Medical Center, Los Angeles Medical Center, University of Rochester Medical Center, Vanderbilt University Medical Center, Hackensack University Medical Center, UPMC Hillman Cancer Center, University of Miami, Sylvester Comprehensive Cancer Center, University of Lille, Inserm, Centre Hospitalier Universitaire de Lille, University of South Florida, Moffitt Cancer Center, Dana-Farber Cancer Institute
Long-Term Follow-up Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
